Business
Virginia theranostics program takes shape with Sentara-BAMF
The joint venture is intended to combine radiopharmaceutical production, molecular imaging, molecular therapy, and clinical trials in a vertically integrated model.
Company
Bamf Health
Clinical
B7-H3 radiopharmaceutical enters first-in-human tumor trial
The first patient in the Phase 1/2a study received the investigational B7-H3-targeted radiopharmaceutical therapy at BAMF Health.